In summary, we demonstrated here for the first time that miRNA-181c and -181d play a tumour suppressive role in BTC by targeting the histone deacetylase SIRT1. As such, they are downregulated in tumour areas and in higher disease stages. This evidence concerns the gene SIRT1 and neoplasm.